"At the new, 86,000 square foot Asplundh Cancer Pavilion, our cancer specialists will have access to all the tools they need to provide top-tier care under one roof, to people living with cancer and their families."

During the past decade, Abington Memorial Hospital-Asplundh Cancer Pavilion conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Abington Memorial Hospital-Asplundh Cancer Pavilion" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator, "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Abington Memorial Hospital-Asplundh Cancer Pavilion" are "Invasive Breast Carcinoma" (2 trials), "Stage II Breast Cancer" (2 trials), "Stage IIA Breast Cancer" (2 trials), "Stage IIB Breast Cancer" (2 trials) and "Stage IIIA Breast Cancer" (2 trials). Many other conditions were trialed in "Abington Memorial Hospital-Asplundh Cancer Pavilion" in a lesser frequency.

Most popular intervention types in "Abington Memorial Hospital-Asplundh Cancer Pavilion" are "Drug" (4 trials), "Other" (4 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "5 FUCMT (chemoradiation)" (1 trials), "Abiraterone Acetate" (1 trials), "Antiandrogen Therapy" (1 trials) and "Cabazitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abington Memorial Hospital-Asplundh Cancer Pavilion" are 3 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Abington Memorial Hospital-Asplundh Cancer Pavilion". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Abington Memorial Hospital-Asplundh Cancer Pavilion, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abington Memorial Hospital-Asplundh Cancer Pavilion, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".